BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33291082)

  • 1. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
    Xu M; Wang J; Li H; Zhang Z; Cheng Z
    Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J; Liu C; Shi J; Wen K; Wang X
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.
    Yang Y; Zhang M; Jin C; Ding Y; Yang M; Wang R; Zhou Y; Zhou Y; Li T; Wang K; Hu R
    J Cell Biochem; 2019 Oct; 120(10):17744-17756. PubMed ID: 31210372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
    Peng C; Li X; Ye Z; Wu W
    Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
    Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
    Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
    Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
    Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absent in melanoma 2 suppresses gastric cancer cell proliferation and migration via inactivation of AKT signaling pathway.
    Wang D; Zou J; Dai J; Cheng Z
    Sci Rep; 2021 Apr; 11(1):8235. PubMed ID: 33859277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.
    Yang M; Huang Q; Li C; Jiang Z; Sun J; Wang Z; Liang R; Li D; Li B; Zhao H
    Front Immunol; 2021; 12():647540. PubMed ID: 33897695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor miR-361-3p inhibits prostate cancer progression through Gli1 and AKT/mTOR signaling pathway.
    Wang S; Huang X; Zhang G; Chen Z; Guan H; Zhou W
    Cell Signal; 2024 Feb; 114():110998. PubMed ID: 38048859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TKP, a serine protease extracted from Trichosanthes kirilowii, inhibits the migration and invasion of colorectal adenocarcinoma cells by targeting Wnt/β-catenin and Hedgehog/Gli1 signalings.
    Sun X; Xu X; Song L
    Phytother Res; 2020 Apr; 34(4):867-878. PubMed ID: 31854039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer.
    Lin WF; Lin XL; Fu SW; Yang L; Tang CT; Gao YJ; Chen HY; Ge ZZ
    Mol Carcinog; 2018 Jul; 57(7):911-925. PubMed ID: 29573464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
    Qin A; Qian W
    Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway.
    Tian L; Deng Z; Xu L; Yang T; Yao W; Ji L; Lu Y; Zhang J; Liu Y; Wang J
    Cell Death Dis; 2018 Nov; 9(11):1115. PubMed ID: 30389910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.